OS THERAPIES INCORPORATED (OSTX) Operating cash flow 2023–2025
OS THERAPIES INCORPORATED (OSTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.2MFY2025 · since FY2023: -$3.0M → -$14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.2M | -95.5% |
| FY2024 | -$7.3M | -142.2% |
| FY2023 | -$3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice